WAVE Life Sciences (WVE)
(Real Time Quote from BATS)
$6.79 USD
-0.17 (-2.44%)
Updated Sep 19, 2025 03:32 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, WAVE Life Sciences Ltd. has a market cap of $1.11B, which represents its share price of $6.96 multiplied by its outstanding shares number of 159.14M. As a small-cap company, WVE's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
WVE 6.79 -0.17(-2.44%)
Will WVE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for WVE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WVE
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
WVE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
Other News for WVE
WVE forms Narrow Range Bar on September 19
The technical outlook for WVE is unchanged after it falls 0.29% on September 18
WVE forms Narrow Range Bar on September 16
Narrow Range Bar appears for WVE after 0.0% move
Is WVE compressing before expansion? NR7 shows up after sinking 2.65%